Grant Details

GRANT OVERVIEW

Grant name and funding organization

Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)

National Institutes of Health (NIH)

Total funding amount and duration

Maximum project period is 5 years.

Application budgets are limited to no more than $499,999 in direct costs per year.

Primary objective and mission statement

To stimulate HIV/AIDS research within the scientific mission areas of the NIDCD.

Applications should address high priority HIV/AIDS research outlined by the NIH Office of AIDS Research.

Key stakeholders and beneficiaries

Individuals with HIV/AIDS.

Researchers in the fields of communication disorders and HIV/AIDS.

ELIGIBILITY CRITERIA

Organization Requirements

Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.

Non-domestic (non-U.S.) entities are also eligible to apply.

Geographic Scope

Open to U.S. and non-domestic entities.

Project Requirements

Projects must address high-priority HIV/AIDS research areas.

Clinical trials must be low-risk and not require FDA oversight.

Financial Requirements

Maximum budget of $499,999 in direct costs per year.

No cost-sharing is required.

Timeline Requirements

Application due dates are set for January 7, 2028.

Letter of Intent due 30 days prior to application due date.

Previous Funding Considerations

Applicants may submit more than one application as long as each is scientifically distinct.

APPLICATION PROCESS

Required documentation and materials

Applications must follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.

Evaluation criteria and scoring system

Applications will be evaluated based on scientific and technical merit.

Review process and timeline

Applications will undergo peer review and will be evaluated for completeness and compliance.

Selection criteria and priorities

Scientific merit and relevance to program priorities will be considered.

SPECIAL CONSIDERATIONS

Unique aspects or requirements

Only low-risk clinical trials will be supported.

Potential challenges or limitations

Applications proposing high-risk clinical trials will be considered non-responsive.

Strategic alignment opportunities

Encouragement of multidisciplinary collaborations.

Competitive advantages or disadvantages

Strong emphasis on addressing communication disorders in individuals with HIV.

KEY INSIGHTS AND RECOMMENDATIONS

Critical success factors

Alignment with NIH research priorities.

Common pitfalls to avoid

Submitting applications that do not comply with the guidelines.

Strategic recommendations for applicants

Engage in early discussions with NIH contacts.

Competitive positioning advice

Highlight unique aspects of the proposed research.

Grant Details

hiv aids research health communication disorders clinical trials epidemiology public health nonprofit higher education
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
PAR-25-319
NIH Grants
PUBLIC EDU NGO ENTERPRISE OTHER
US AF
RESEARCH_DEVELOPMENT
False
499999.00
None
499999.00
USD
None
True
True
To improve the health of individuals living with HIV through targeted research in communication disorders.
Research findings that inform treatment and prevention strategies for communication disorders in individuals with HIV.
Jan. 7, 2028, 10 p.m.
March 2028
Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
True
Scientific merit and relevance to program priorities.
Addressing significant unmet needs in HIV/AIDS research.
Proposed research must be scientifically sound and feasible.
Potential to significantly influence the field of HIV/AIDS research.
True
True
Grant
Compliance with NIH Grants Policy Statement.
Annual reporting on progress and financial statements.
Payments based on milestones and compliance with reporting requirements.
NIH Grants Policy Statement and applicable federal regulations.
None specified.